Skip to content

ALT levels may not give true picture of liver disease in HIV/HCV coinfected, suggests study

Risk of altered blood fat levels varies according to ethnic background, study shows

Fatigue may be misdiagnosed as depression during anti-HCV therapy in HIV coinfected

Fat loss associated with Combivir but not Truvada

Unusual abacavir hypersensitivity reaction involving severe respiratory symptoms reported

Increase ribavirin dose for better HCV treatment response in coinfected individuals, experts argue

HAART reduces liver-related death risk, but hepatitis C infection increases risk, Italian study finds

HIV/HCV coinfected patients have poorer immunologic response to HIV treatment

Immune reconstitution syndrome risk highest in those commencing HIV therapy with advanced HIV disease